Answer
Glibenclamide may increase ciclosporin plasma concentrations and potentially its toxicity, so ciclosporin monitoring and dose adjustment are recommended when the medicines are co-administered.
Sources for this answer
- AMGLIDIA 0.6 mg/mL oral suspension with 1 mL oral syringeBioprojet UK Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 4Document updated
Sources checked